Celcuity to present at investor conferences
Analysis based on 6 articles · First reported May 28, 2026 · Last updated May 28, 2026
Celcuity, a clinical-stage biotechnology company, announced that its CEO and Co-founder, Brian Sullivan, will participate in two upcoming investor conferences: the Jefferies Global Healthcare Conference on June 4, 2026, and the Goldman Sachs 47th Annual Global Healthcare Conference 2026 on June 10, 2026. These presentations will include fireside chats and one-on-one investor meetings, providing an opportunity for Celcuity to showcase its targeted therapies for solid tumor indications, including its lead therapeutic candidate, gedatolisib, and ongoing Phase 3 clinical trials.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard